MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Search

Certara Inc

Închisă

SectorSănătate

11.45 0.44

Rezumat

Modificarea prețului

24h

Curent

Minim

11.17

Maxim

11.53

Indicatori cheie

By Trading Economics

Venit

-1.8M

4.7M

Vânzări

5.6M

106M

EPS

0.029

Marjă de profit

4.474

Angajați

1,487

EBITDA

-25M

609K

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+42.54% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-324M

1.8B

Deschiderea anterioară

11.01

Închiderea anterioară

11.45

Sentimentul știrilor

By Acuity

50%

50%

157 / 376 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Certara Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 iul. 2025, 15:46 UTC

Principalele dinamici ale pieței

BitMine Shares Fall After Closing of $250 Million Private Placement

9 iul. 2025, 23:44 UTC

Market Talk

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9 iul. 2025, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 iul. 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9 iul. 2025, 22:59 UTC

Market Talk

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9 iul. 2025, 22:59 UTC

Market Talk

Global Equities Roundup: Market Talk

9 iul. 2025, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

9 iul. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 iul. 2025, 20:26 UTC

Câștiguri

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9 iul. 2025, 19:18 UTC

Market Talk

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9 iul. 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9 iul. 2025, 18:31 UTC

Market Talk

Some Fed Officials Supported Considering July Cut -- Market Talk

9 iul. 2025, 17:07 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9 iul. 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk -2-

9 iul. 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9 iul. 2025, 16:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

9 iul. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 iul. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9 iul. 2025, 16:14 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 iul. 2025, 16:14 UTC

Market Talk

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9 iul. 2025, 16:14 UTC

Achiziții, Fuziuni, Preluări

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9 iul. 2025, 16:12 UTC

Market Talk

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9 iul. 2025, 16:08 UTC

Market Talk

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9 iul. 2025, 15:31 UTC

Principalele dinamici ale pieței

BitMine Shares Fall After Closing of $250M Private Placement

9 iul. 2025, 15:31 UTC

Market Talk
Achiziții, Fuziuni, Preluări

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9 iul. 2025, 15:27 UTC

Market Talk

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9 iul. 2025, 14:36 UTC

Achiziții, Fuziuni, Preluări

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9 iul. 2025, 14:31 UTC

Achiziții, Fuziuni, Preluări

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9 iul. 2025, 14:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

9 iul. 2025, 14:26 UTC

Market Talk

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Comparație

Modificare preț

Certara Inc Așteptări

Obiectiv de preț

By TipRanks

42.54% sus

Prognoză pe 12 luni

Medie 15.58 USD  42.54%

Maxim 18 USD

Minim 14 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCertara Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

8 ratings

3

Cumpărare

5

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

11.27 / 12.79Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Very Strong Bullish Evidence

Termen lung

Strong Bullish Evidence

Sentiment

By Acuity

157 / 376 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.